Saponins in Chinese Herbal Medicine Exerts Protection in Myocardial Ischemia-Reperfusion Injury: Possible Mechanism and Target Analysis
- PMID: 33597866
- PMCID: PMC7883640
- DOI: 10.3389/fphar.2020.570867
Saponins in Chinese Herbal Medicine Exerts Protection in Myocardial Ischemia-Reperfusion Injury: Possible Mechanism and Target Analysis
Abstract
Myocardial ischemia is a high-risk disease among middle-aged and senior individuals. After thrombolytic therapy, heart tissue can potentially suffer further damage, which is called myocardial ischemia-reperfusion injury (MIRI). At present, the treatment methods and drugs for MIRI are scarce and cannot meet the current clinical needs. The mechanism of MIRI involves the interaction of multiple factors, and the current research hotspots mainly include oxidative stress, inflammation, calcium overload, energy metabolism disorders, pyroptosis, and ferroptosis. Traditional Chinese medicine (TCM) has multiple targets and few toxic side effects; clinical preparations containing Panax ginseng C. A. Mey., Panax notoginseng (Burk.) F. H. Chen, Aralia chinensis L., cardioprotection, and other Chinese herbal medicines have been used to treat patients with coronary heart disease, angina pectoris, and other cardiovascular diseases. Studies have shown that saponins are the main active substances in TCMs containing Panax ginseng C. A. Mey., Panax notoginseng (Burk.) F. H. Chen, Aralia chinensis L., and Radix astragali. In the present review, we sorted the saponin components with anti-MIRI effects and their regulatory mechanisms. Each saponin can play a cardioprotective role via multiple mechanisms, and the signaling pathways involved in different saponins are not the same. We found that more active saponins in Panax ginseng C. A. Mey. are mainly dammar-type structures and have a strong regulatory effect on energy metabolism. The highly active saponin components of Aralia chinensis L. are oleanolic acid structures, which have significant regulatory effects on calcium homeostasis. Therefore, saponins in Chinese herbal medicine provide a broad application prospect for the development of highly effective and low-toxicity anti-MIRI drugs.
Keywords: aralia saponins; ginsenosides; mechanism; myocardial ischemia-reperfusion injury; saponins; traditional Chinese medicine.
Copyright © 2021 Wang, Wang, Zhou, Wu, Ye, Sun and Sun.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures




Similar articles
-
[Advances in pharmacological studies of Panax notoginseng saponins on brain ischemia-reperfusion injury].Yao Xue Xue Bao. 2016 Jul;51(7):1039-46. Yao Xue Xue Bao. 2016. PMID: 29896950 Review. Chinese.
-
[Advances in pharmacological studies of Panax notoginseng saponins on brain ischemia-reperfusion injury].Yao Xue Xue Bao. 2016 Jul;51(7):1039-46. Yao Xue Xue Bao. 2016. PMID: 29896951 Chinese.
-
Total Saponins of Aralia Elata (Miq) Seem Alleviate Calcium Homeostasis Imbalance and Endoplasmic Reticulum Stress-Related Apoptosis Induced by Myocardial Ischemia/Reperfusion Injury.Cell Physiol Biochem. 2018;50(1):28-40. doi: 10.1159/000493954. Epub 2018 Oct 2. Cell Physiol Biochem. 2018. PMID: 30278458
-
Panax notoginseng saponins dually modulates autophagy in gastric precancerous lesions complicated with myocardial ischemia-reperfusion injury model through the PI3K/AKT/mTOR pathway.Biomed Pharmacother. 2024 Sep;178:117268. doi: 10.1016/j.biopha.2024.117268. Epub 2024 Aug 7. Biomed Pharmacother. 2024. PMID: 39116780
-
Panax ginseng against myocardial ischemia/reperfusion injury: A review of preclinical evidence and potential mechanisms.J Ethnopharmacol. 2023 Jan 10;300:115715. doi: 10.1016/j.jep.2022.115715. Epub 2022 Sep 13. J Ethnopharmacol. 2023. PMID: 36108895 Review.
Cited by
-
Taohong Siwu Decoction Combined With the LncRNA H19/miR-675-5p Axis Repairs Limb Ischemia-Reperfusion Injury Through the Regulation of the Wnt3a/Ca2+ Signaling Pathway.Mediators Inflamm. 2025 Feb 23;2025:3096848. doi: 10.1155/mi/3096848. eCollection 2025. Mediators Inflamm. 2025. PMID: 40034562 Free PMC article.
-
Xinshuaining preparation ameliorates doxorubicin-induced cardiac injury in heart failure rats by regulating gut microbiota.Drug Deliv Transl Res. 2025 May 26. doi: 10.1007/s13346-025-01879-9. Online ahead of print. Drug Deliv Transl Res. 2025. PMID: 40419735
-
Ferroptosis and myocardial ischemia-reperfusion: mechanistic insights and new therapeutic perspectives.Front Pharmacol. 2024 Oct 1;15:1482986. doi: 10.3389/fphar.2024.1482986. eCollection 2024. Front Pharmacol. 2024. PMID: 39411064 Free PMC article. Review.
-
Inhibiting Angiogenesis by Anti-Cancer Saponins: From Phytochemistry to Cellular Signaling Pathways.Metabolites. 2023 Feb 22;13(3):323. doi: 10.3390/metabo13030323. Metabolites. 2023. PMID: 36984763 Free PMC article. Review.
-
Neuroprotective Effects and Metabolomics Study of Protopanaxatriol (PPT) on Cerebral Ischemia/Reperfusion Injury In Vitro and In Vivo.Int J Mol Sci. 2023 Jan 16;24(2):1789. doi: 10.3390/ijms24021789. Int J Mol Sci. 2023. PMID: 36675303 Free PMC article.
References
-
- Alegre P., Mathias L., Lourenco M. A., Santos P. P. D., Goncalves A., Fernandes A. A., et al. (2020). Euterpe oleracea Mart. (Açaí) reduces oxidative stress and improves energetic metabolism in myocardial ischemia-reperfusion injury in rats. Arq. Bras. Cardiol. 114, 78–86. 10.36660/abc.20180140 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources